CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

The year in cardiovascular medicine 2020: heart failure and cardiomyopathies H2FPEF Score for Predicting Future Heart Failure in Stable Outpatients With Cardiovascular Risk Factors Modifiable lifestyle factors and heart failure: A Mendelian randomization study Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) Risk of Mortality Following Catheter Ablation of Atrial Fibrillation Primary Prevention of Heart Failure in Women Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial

Expert Opinion03 January 2021

JOURNAL:Eur Heart J. Article Link

The year in cardiovascular medicine 2020: heart failure and cardiomyopathies

H Bueno, B Moura, P Lancellotti et al. Keywords: heart failure; cardiomyopathies

Full Text PDF